According to a market report by Lucintel, the future of the global blood cancer diagnostic market looks promising with opportunities in the hospital & clinic, diagnostic lab, and research institute markets. The global blood cancer diagnostic market is expected to grow with a CAGR of 6.9% from 2025 to 2031. The major drivers for this market are the increasing prevalence of blood cancers, the growing demand for early diagnosis, and the rising adoption of genetic testing.
A more
than 150-page report to understand trends, opportunity and forecast in global
blood cancer diagnostic market to 2031 by product (instruments and assay kits
& reagents), test (blood tests, imaging tests, biopsy, and molecular test),
end use (hospitals & clinics, diagnostic labs, research institutes, and
others), and region (North America, Europe, Asia Pacific, and the Rest of the
World).
Lucintel
forecasts that, within the product category, assay kit & reagent is
expected to witness higher growth over the forecast period.
Within the
application category, hospital & clinic is expected to witness the highest
growth.
Download
sample by clicking on blood cancer diagnostic market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Quest
Diagnostics, Illumina, InVivoScribe, Ipsogen, Asuragen, Danaher Corporation,
Abbott, Sequenta, SkylineDx, Bio-Rad Laboratories are the major suppliers in
the blood cancer diagnostic market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get
access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment